Home › Funds › SNYDER CAPITAL MANAGEMENT L P › CRL
SNYDER CAPITAL MANAGEMENT L P position in CRL
CHARLES RIV LABS INTL INC · Health Care
SNYDER CAPITAL MANAGEMENT L P reported holding 272,635 shares of CRL (CHARLES RIV LABS INTL INC) in its Q3 2026 13F filing — a position valued at US$80.4M, representing 1.58% of its reported portfolio and ranking #23 among its reported holdings. SNYDER CAPITAL MANAGEMENT L P has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How SNYDER CAPITAL MANAGEMENT L P's CRL position evolved
SNYDER CAPITAL MANAGEMENT L P first disclosed a stake in CRL in Q3 2023 at 154,834 shares (US$30.3M). The position peaked in Q3 2026 at 272,635 shares, worth US$80.4M. Across 13 filings, SNYDER CAPITAL MANAGEMENT L P increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 272,635 shares valued at US$80.4M — a reduction of -9,121 shares quarter over quarter.. Notable position changes include a 35% increase in Q4 2025 (shares fell 14% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 154.83K | $30.34M | New |
| Q4 2023 | 147.34K | $34.83M | Reduce |
| Q1 2024 | 138.15K | $37.43M | Reduce |
| Q2 2024 | 135.64K | $28.02M | Reduce |
| Q3 2024 | 153.84K | $30.30M | Add |
| Q4 2024 | 177.93K | $32.85M | Add |
| Q1 2025 | 174.26K | $26.23M | Reduce |
| Q2 2025 | 181.11K | $27.48M | Add |
| Q3 2025 | 177.91K | $27.84M | Reduce |
| Q4 2025 | 240.96K | $48.07M | Add |
| Q1 2026 | 237.71K | $41.00M | Reduce |
| Q2 2026 | 281.76K | $63.90M | Add |
| Q3 2026 | 272.63K | $80.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CRL and 13F data
CRL (CHARLES RIV LABS INTL INC) is a Health Care company. 31 other funds we track also report a position in CRL — the largest reported positions include ARIEL INVESTMENTS, LLC (US$352.0M), EARNEST PARTNERS LLC (US$320.7M), Allspring Global Investments Holdings, LLC (US$254.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRL
- ARIEL INVESTMENTS, LLC 1.19M sh · $352.05M · Q3 2026
- EARNEST PARTNERS LLC 1.09M sh · $320.67M · Q3 2026
- Allspring Global Investments Holdings, LLC 887.52K sh · $254.57M · Q3 2026
- COOKE & BIELER LP 432.12K sh · $127.48M · Q3 2026
More on SNYDER CAPITAL MANAGEMENT L P
FAQ
How long has SNYDER CAPITAL MANAGEMENT L P held CRL?
SNYDER CAPITAL MANAGEMENT L P has disclosed CRL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SNYDER CAPITAL MANAGEMENT L P's current position in CRL?
As of Q3 2026, SNYDER CAPITAL MANAGEMENT L P holds 272.63K shares of CRL (CHARLES RIV LABS INTL INC), valued at $80.43M, representing 1.58% of its reported portfolio and ranking #23.
Has SNYDER CAPITAL MANAGEMENT L P been buying or selling CRL?
In the latest 13F filing (Q3 2026), SNYDER CAPITAL MANAGEMENT L P reduced its position in CRL. The position peaked in Q3 2026 at 272.63K shares.
Which other funds hold CRL?
Other major institutional holders of CRL include ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, Allspring Global Investments Holdings, LLC, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.